Featured Research

from universities, journals, and other organizations

Sexual health of men with chronic heart failure significantly improves with CRT, study finds

Date:
June 2, 2011
Source:
Wiley-Blackwell
Summary:
A new study reveals that in men with chronic heart failure, cardiac resynchronization therapy improves patients' libido, erectile dysfunction, and sexual performance.

A new study published in the journal Clinical Cardiology reveals that in men with chronic heart failure, cardiac resynchronization therapy (CRT) improves patients' libido, erectile dysfunction, and sexual performance.

Related Articles


Chronic heart failure (HF) is a common, complex clinical syndrome characterized by fatigue and exercise intolerance. HF patients experience decreased libido and erectile dysfunction (ED). CRT, which is a type of pacemaker that paces the right and left ventricle, is used to treat patients with HF.

Led by Ahmet Vural of Kocaeli University, researchers investigated the effects of CRT on libido and ED. 31 male patients with advanced HF, scheduled for implantation of a CRT device, were included in the study. They were assessed before and six months after CRT.

At the six-month follow-up after CRT, 23 patients reported no ED, and only two patients had moderate ED. Severe ED was not found in any patient. A significant increase in patients with normal libido was found, with 25 men reporting improvement compared to only three reporting normal libido prior to CRT.

The findings show that CRT results in significant improvement in libido, ED, and sexual performance as a consequence of the improvement in functional capacity and ejection fraction.

"Not only does CRT decrease mortality in heart failure patients, it also brings improvement in sexual health to the patient's life," Vural concludes.


Story Source:

The above story is based on materials provided by Wiley-Blackwell. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ahmet Vural, Aysen Agacdiken, Umut Celikyurt, Melih Culha, Goksel Kahraman, Guliz Kozdag, Dilek Ural. Effect of Cardiac Resynchronization Therapy on Libido and Erectile Dysfunction. Clinical Cardiology, 2011; DOI: 10.1002/clc.20918

Cite This Page:

Wiley-Blackwell. "Sexual health of men with chronic heart failure significantly improves with CRT, study finds." ScienceDaily. ScienceDaily, 2 June 2011. <www.sciencedaily.com/releases/2011/06/110602081836.htm>.
Wiley-Blackwell. (2011, June 2). Sexual health of men with chronic heart failure significantly improves with CRT, study finds. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/2011/06/110602081836.htm
Wiley-Blackwell. "Sexual health of men with chronic heart failure significantly improves with CRT, study finds." ScienceDaily. www.sciencedaily.com/releases/2011/06/110602081836.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Liberia Releases Last Ebola Patient, But Threat Remains

Liberia Releases Last Ebola Patient, But Threat Remains

Newsy (Mar. 5, 2015) Liberia&apos;s last Ebola patient has been released, and the country hasn&apos;t recorded a new case in a week. However, fears of another outbreak still exist. Video provided by Newsy
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins